ADAP
Morgan Stanley’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
4,232,268
+1,516,321
| +56% | +$363K | ﹤0.01% | 5094 |
|
|
2025
Q1 | $535K | Buy |
2,715,947
+1,391,083
| +105% | +$274K | ﹤0.01% | 5296 |
|
|
2024
Q4 | $714K | Sell |
1,324,864
-374,161
| -22% | -$202K | ﹤0.01% | 5261 |
|
|
2024
Q3 | $1.61M | Buy |
1,699,025
+1,258,193
| +285% | +$1.2M | ﹤0.01% | 4771 |
|
|
2024
Q2 | $430K | Buy |
440,832
+67,551
| +18% | +$65.9K | ﹤0.01% | 5362 |
|
|
2024
Q1 | $590K | Sell |
373,281
-3,540,035
| -90% | -$5.59M | ﹤0.01% | 5235 |
|
|
2023
Q4 | $3.1M | Buy |
3,913,316
+1,861,970
| +91% | +$1.48M | ﹤0.01% | 4686 |
|
|
2023
Q3 | $1.6M | Sell |
2,051,346
-25,826
| -1% | -$20.1K | ﹤0.01% | 4524 |
|
|
2023
Q2 | $1.92M | Sell |
2,077,172
-175,252
| -8% | -$162K | ﹤0.01% | 4450 |
|
|
2023
Q1 | $2.46M | Sell |
2,252,424
-37,424
| -2% | -$40.8K | ﹤0.01% | 4327 |
|
|
2022
Q4 | $3.34M | Buy |
2,289,848
+22,082
| +1% | +$32.2K | ﹤0.01% | 4090 |
|
|
2022
Q3 | $2.44M | Buy |
2,267,766
+187,297
| +9% | +$201K | ﹤0.01% | 4285 |
|
|
2022
Q2 | $3.54M | Buy |
2,080,469
+27,034
| +1% | +$45.9K | ﹤0.01% | 4072 |
|
|
2022
Q1 | $4.23M | Sell |
2,053,435
-190,038
| -8% | -$391K | ﹤0.01% | 3860 |
|
|
2021
Q4 | $8.41M | Buy |
2,243,473
+1,908,502
| +570% | +$7.16M | ﹤0.01% | 3133 |
|
|
2021
Q3 | $1.73M | Sell |
334,971
-1,953,560
| -85% | -$10.1M | ﹤0.01% | 4677 |
|
|
2021
Q2 | $9.75M | Sell |
2,288,531
-2,435,031
| -52% | -$10.4M | ﹤0.01% | 3020 |
|
|
2021
Q1 | $25.1M | Sell |
4,723,562
-663,926
| -12% | -$3.53M | ﹤0.01% | 1707 |
|
|
2020
Q4 | $29M | Buy |
5,387,488
+5,092,210
| +1,725% | +$27.4M | ﹤0.01% | 1493 |
|
|
2020
Q3 | $2.36M | Buy |
295,278
+257,361
| +679% | +$2.05M | ﹤0.01% | 3512 |
|
|
2020
Q2 | $380K | Buy |
37,917
+9,272
| +32% | +$92.9K | ﹤0.01% | 4742 |
|
|
2020
Q1 | $77K | Buy |
28,645
+2,782
| +11% | +$7.48K | ﹤0.01% | 5296 |
|
|
2019
Q4 | $31K | Sell |
25,863
-377,598
| -94% | -$453K | ﹤0.01% | 5983 |
|
|
2019
Q3 | $609K | Buy |
403,461
+245,523
| +155% | +$371K | ﹤0.01% | 4597 |
|
|
2019
Q2 | $635K | Sell |
157,938
-78,849
| -33% | -$317K | ﹤0.01% | 4480 |
|
|
2019
Q1 | $1.02M | Buy |
236,787
+187,604
| +381% | +$807K | ﹤0.01% | 4100 |
|
|
2018
Q4 | $283K | Buy |
49,183
+40,913
| +495% | +$235K | ﹤0.01% | 5128 |
|
|
2018
Q3 | $112K | Sell |
8,270
-239,452
| -97% | -$3.24M | ﹤0.01% | 5652 |
|
|
2018
Q2 | $2.94M | Buy |
247,722
+90,964
| +58% | +$1.08M | ﹤0.01% | 3714 |
|
|
2018
Q1 | $1.76M | Buy |
156,758
+96,119
| +159% | +$1.08M | ﹤0.01% | 4120 |
|
|
2017
Q4 | $405K | Buy |
60,639
+29,515
| +95% | +$197K | ﹤0.01% | 5087 |
|
|
2017
Q3 | $254K | Buy |
31,124
+21,753
| +232% | +$178K | ﹤0.01% | 5233 |
|
|
2017
Q2 | $42K | Buy |
9,371
+698
| +8% | +$3.13K | ﹤0.01% | 5903 |
|
|
2017
Q1 | $48K | Buy |
+8,673
| New | +$48K | ﹤0.01% | 5842 |
|
|
2016
Q4 | – | Sell |
-3,570
| Closed | -$25K | – | 6515 |
|
|
2016
Q3 | $25K | Sell |
3,570
-4,624
| -56% | -$32.4K | ﹤0.01% | 5839 |
|
|
2016
Q2 | $67K | Sell |
8,194
-1,437
| -15% | -$11.8K | ﹤0.01% | 5418 |
|
|
2016
Q1 | $78K | Buy |
9,631
+4,443
| +86% | +$36K | ﹤0.01% | 5426 |
|
|
2015
Q4 | $62K | Buy |
5,188
+2,666
| +106% | +$31.9K | ﹤0.01% | 5629 |
|
|
2015
Q3 | $30K | Sell |
2,522
-8,995
| -78% | -$107K | ﹤0.01% | 5907 |
|
|
2015
Q2 | $211K | Buy |
+11,517
| New | +$211K | ﹤0.01% | 5204 |
|